Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,487,984
  • Shares Outstanding, K 5,667,340
  • Annual Sales, $ 63,627 M
  • Annual Income, $ 8,031 M
  • EBIT $ 17,697 M
  • EBITDA $ 24,710 M
  • 60-Month Beta 0.61
  • Price/Sales 2.34
  • Price/Cash Flow 6.01
  • Price/Book 1.68

Options Overview Details

View History
  • Implied Volatility 27.99% ( +1.66%)
  • Historical Volatility 20.09%
  • IV Percentile 80%
  • IV Rank 67.63%
  • IV High 32.70% on 04/12/24
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.59
  • Today's Volume 182,356
  • Volume Avg (30-Day) 163,617
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 2,948,112
  • Open Int (30-Day) 3,029,915

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.67
  • Number of Estimates 6
  • High Estimate 0.81
  • Low Estimate 0.54
  • Prior Year 0.82
  • Growth Rate Est. (year over year) -18.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.17 +5.84%
on 02/12/25
27.24 -2.20%
on 03/10/25
+0.77 (+2.98%)
since 02/10/25
3-Month
25.06 +6.30%
on 12/12/24
27.57 -3.37%
on 01/07/25
+1.07 (+4.18%)
since 12/10/24
52-Week
24.48 +8.82%
on 11/15/24
31.54 -15.54%
on 07/30/24
-0.58 (-2.13%)
since 03/08/24

Most Recent Stories

More News
BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic

For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.

IBB : 135.84 (-0.81%)
FNDF : 36.31 (-1.94%)
PFE : 26.64 (-0.34%)
BNTX : 105.35 (-3.15%)
Bristol Myers Stock Gains 9.2% in a Month: Should You Buy Now or Wait?

Shares of Bristol Myers BMY have risen 9.2% in the past month compared with the medical biomedical and genetics industry’s growth of 5%.  The stock has also outperformed the industry and the sector...

MRK : 95.23 (+0.61%)
PFE : 26.64 (-0.34%)
BMY : 63.11 (+3.31%)
The State of Weight Loss Drugs

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss:

GIS : 65.30 (+1.24%)
VKTX : 27.96 (-3.92%)
NVO : 78.95 (-9.43%)
HIMS : 34.47 (-4.12%)
LLY : 829.76 (-4.58%)
CAG : 27.62 (+1.43%)
GPCR : 20.16 (-10.88%)
ISRG : 482.61 (-6.88%)
PFE : 26.64 (-0.34%)
Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?

Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ups and downs in between, after it took a hammering in the past couple of years...

NVO : 78.95 (-9.43%)
LLY : 829.76 (-4.58%)
ABBV : 216.66 (+1.11%)
PFE : 26.64 (-0.34%)
BioNTech Surpasses Q4 Revenue Estimates

BioNTech SE exceeded earnings expectations with strong oncology pipeline development, despite reduced vaccine revenue.

MRNA : 35.96 (+0.98%)
PFE : 26.64 (-0.34%)
BNTX : 105.35 (-3.15%)
3 Reasons PFE is Risky and 1 Stock to Buy Instead

3 Reasons PFE is Risky and 1 Stock to Buy Instead

MELI : 1,944.61 (-3.22%)
PFE : 26.64 (-0.34%)
3 ETFs to Buy Now for Passive Dividend Income

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) down on the year, investors may be looking for ways to diversify their portfolios...

AAPL : 227.48 (-4.85%)
CSCO : 62.06 (-2.94%)
AVGO : 184.45 (-5.39%)
VTC : 76.79 (+0.34%)
JNJ : 167.70 (+0.61%)
AMGN : 327.36 (+0.77%)
PFE : 26.64 (-0.34%)
UNH : 480.22 (-2.27%)
COMP : 8.57 (+1.06%)
MSFT : 380.16 (-3.34%)
COST : 934.41 (-3.10%)
MA : 537.12 (-1.76%)
3 Top Dividend Stocks to Buy in March

Investing in dividend stocks can be a great strategy, especially if you pick solid companies that pay reliable and high-yield dividends. While dividend stocks don't always offer the same excitement as...

VZ : 46.49 (+0.93%)
PFE : 26.64 (-0.34%)
O : 58.49 (+0.02%)
The Nasdaq Is Falling: 4 of the Safest Stocks to Buy Right Now

A double-digit percentage decline in Wall Street's highest-flying stock index spells opportunity for value-oriented investors.

COMP : 8.57 (+1.06%)
GOOGL : 165.87 (-4.60%)
GOOG : 167.81 (-4.52%)
YORW : 35.00 (+1.51%)
$NASX : 17,468.32 (unch)
SIRI : 24.39 (-3.33%)
PFE : 26.64 (-0.34%)
The Smartest Dividend Stocks to Buy With $2,000 Right Now

There are lots of good dividend stocks to consider stepping into here, but only a few truly great income-producing prospects.

TMUS : 266.63 (+0.52%)
CMCSA : 36.11 (-3.94%)
VZ : 46.49 (+0.93%)
T : 27.28 (+0.59%)
BTI : 40.56 (-0.83%)
CHTR : 373.52 (-1.58%)
PFE : 26.64 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 27.77
2nd Resistance Point 27.51
1st Resistance Point 27.07
Last Price 26.64
1st Support Level 26.37
2nd Support Level 26.11
3rd Support Level 25.67

See More

52-Week High 31.54
Fibonacci 61.8% 28.84
Fibonacci 50% 28.01
Fibonacci 38.2% 27.18
Last Price 26.64
52-Week Low 24.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar